However, ER stress-induced upregulation of the PERK-eIF2a phosphorylation pathway was shown to be associated with imatinib resistance in CML cell lines and CD34+ cells from CML patients [25]. The gene discussed is EIF2AK3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.